Annals of Medicine and Medical Sciences
Blinatumomab for Minimal Residual Disease Clearance in B-Acute Lymphoblastic Leukemia
Objective: To evaluate the efficacy, safety, and clinical impact of blinatumomab across the treatment continuum of B-cell acute lymphoblastic leukemia. Design…
By Dr. Suhena Sarkar, MD | Mar 1, 2026
Mar 1, 2026